It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The structural basis for the allosteric interactions within G protein-coupled receptors (GPCRs) heterodimers remains largely unknown. The metabotropic glutamate (mGlu) receptors are complex dimeric GPCRs important for the fine tuning of many synapses. Heterodimeric mGlu receptors with specific allosteric properties have been identified in the brain. Here we report four cryo-electron microscopy structures of mGlu2-4 heterodimer in different states: an inactive state bound to antagonists, two intermediate states bound to either mGlu2 or mGlu4 agonist only and an active state bound to both glutamate and a mGlu4 positive allosteric modulator (PAM) in complex with Gi protein. In addition to revealing a unique PAM binding pocket among mGlu receptors, our data bring important information for the asymmetric activation of mGlu heterodimers. First, we show that agonist binding to a single subunit in the extracellular domain is not sufficient to stabilize an active dimer conformation. Single-molecule FRET data show that the monoliganded mGlu2-4 can be found in both intermediate states and an active one. Second, we provide a detailed view of the asymmetric interface in seven-transmembrane (7TM) domains and identified key residues within the mGlu2 7TM that limits its activation leaving mGlu4 as the only subunit activating G proteins.
Metabotropic glutamate receptors exist as both homo- and heterodimers. Here, the authors report the mGlu2-4 receptor structures in the inactive, intermediate and active states, and reveal the reason for the partial activity of the mono-liganded dimers.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 Huazhong University of Science and Technology (HUST), Key Laboratory of Molecular Biophysics of MOE, College of Life Science and Technology, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223); Huazhong University of Science and Technology (HUST), International Research Center for Sensory Biology and Technology of MOST, College of Life Science and Technology, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223)
2 Huazhong University of Science and Technology (HUST), Key Laboratory of Molecular Biophysics of MOE, College of Life Science and Technology, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223); Huazhong University of Science and Technology (HUST), International Research Center for Sensory Biology and Technology of MOST, College of Life Science and Technology, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223); Zhejiang University School of Medicine, Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital, Hangzhou, China (GRID:grid.415999.9) (ISNI:0000 0004 1798 9361)
3 Zhejiang University School of Medicine, Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital, Hangzhou, China (GRID:grid.415999.9) (ISNI:0000 0004 1798 9361); Zhejiang University, Liangzhu Laboratory, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)
4 Huazhong University of Science and Technology (HUST), Key Laboratory of Molecular Biophysics of MOE, College of Life Science and Technology, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223); Huazhong University of Science and Technology (HUST), International Research Center for Sensory Biology and Technology of MOST, College of Life Science and Technology, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223); Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Bioland Laboratory, Guangzhou, China (GRID:grid.508040.9) (ISNI:0000 0004 9415 435X)
5 Zhejiang University School of Medicine, Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital, Hangzhou, China (GRID:grid.415999.9) (ISNI:0000 0004 1798 9361)
6 Centre de Biologie Structurale (CBS), Univ. Montpellier, CNRS, INSERM, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141)
7 Zhejiang University, Liangzhu Laboratory, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)
8 Institut de Génomique Fonctionnelle (IGF), Univ. Montpellier, CNRS, INSERM, Montpellier, France (GRID:grid.461890.2) (ISNI:0000 0004 0383 2080)
9 Zhejiang University School of Medicine, Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital, Hangzhou, China (GRID:grid.415999.9) (ISNI:0000 0004 1798 9361); Zhejiang University, Liangzhu Laboratory, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Zhejiang University School of Medicine, Center for Structural Pharmacology and Therapeutics Development, Sir Run Run Shaw Hospital, Hangzhou, China (GRID:grid.415999.9) (ISNI:0000 0004 1798 9361); Zhejiang University School of Medicine, MOE Frontier Science Center for Brain Research and Brain-Machine Integration, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)